Morphine IR & ER

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DLA TROOP SUPPORT

Contract Value

Not provided

Codes & Classification
Solicitation Number

SPE2D2-26-D-0004

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

Hobart, New York, UNITED STATES

SourceSAM
Documents3
The Defense Logistics Agency (DLA) Troop Support, operating under the Department of Defense, has issued an award notice for the procurement of Morphine Immediate Release (IR) and Extended Release (ER) tablets. This contract, identified by procurement number SPE2D2-26-D-0004, is classified under NAICS code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is further categorized by Product Service Code 6505, indicating drugs and biologicals. The primary objective of this procurement is to ensure a reliable supply of Morphine IR and ER tablets to meet the medical and operational needs of the Department of Defense. The scope of the contract encompasses the manufacturing and delivery of these pharmaceutical products, with the place of performance specified as Hobart, New York, United States. The intended outcome is to maintain an uninterrupted availability of critical pain management medications for military personnel and associated healthcare facilities. Key requirements for this contract include adherence to stringent pharmaceutical manufacturing standards, compliance with all applicable federal regulations, and the ability to deliver both immediate and extended release formulations of morphine. Contractors are expected to demonstrate robust quality assurance processes and the capacity to fulfill the volume and delivery schedules as stipulated by DLA Troop Support. The contracting entity for this award is DLA Troop Support, a federal office within the Defense Logistics Agency. The primary point of contact for this procurement is Christopher Newman ([email protected], 445-737-7371), with Catherine Gilbert ([email protected], 445-737-8868) serving as the secondary contact. Interested parties can access further details and attachments related to this award via the official SAM.gov opportunity page at https://sam.gov/opp/40138a7682a74e33b6e2efc69cc75a89/view. This procurement is an award notice, indicating that the contract has already been issued and is currently active as of October 26, 2026. There are no explicit set-aside requirements or special considerations noted in the available information. Contractors evaluating this opportunity should note that the core elements—manufacture and supply of Morphine IR and ER tablets to a federal defense entity, compliance with pharmaceutical standards, and performance in Hobart, NY—will remain constant throughout the contract lifecycle.